CMP vs Fascia Iliaca Block

Not Applicable

• Conditions: Hip Arthroplasty; Pain, Postoperative
• Interventions: Drug: Fascia Illica; Drug: CMP

• Registration Number: NCT04426058
• Lead Sponsor: Loyola University

Brief Summary

Complete motorsparing protocol (CMP) has been developed to try to minimize the motor nerve block that is created when using Facia iliaca nerve block. The blocks performed in the (CMP) are the cluneal nerve block, Pericapsular nerve group block and lateral femoral cutaneous block. On the clinical trial, the investigators will randomize the participants that meet criteria to CMP or Fascia iliaca Block and compare the amount of opioid needed post op during 24 hours and their pain scores.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-05-13
• Study Start: 2020-06-06
• Study First Submitted QC: 2020-06-09
• Study First Posted: 2020-06-11
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-12
• Last Update Posted: 2022-04-20
• Primary Completion: 2022-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Patients ≥ 18 years old
• Patients undergoing total hip arthroplasty posterior approach.
• Patients willing to participate and sign informed consent

Exclusion Criteria

• Severe COPD/other contraindication to general anesthesia that spinal would be more suitable.
• Patient with a weight of less than 41 kg
• Dementia, not alert or Oriented to person, place, or time
• Chronic pain patient with daily opioid use at home.
• Patient with allergy to local anesthetics
• Patient refusal
• Total hip arthroplasty revision
• Concomitant pain in different area from operative site.
• Pregnancy
• Patient with active infection on the injection sites for the blocks
• Patients unable or willing to understand or comply with the study protocol

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Fascia iliaca	Fascia Illica	Fascia iliaca block suprainguinal technique 0.25% bupivacaine 50ml
CMP	CMP	Cluneal nerve Block 0.25% bupivacaine 20ml Pericapsular Nerve group block 0.25% Bupivacaine 20ml Lateral femoral cutaneous Block 0.25% bupivacaine 10ml

Primary Outcome Measures

Name	Time	Method
Measurement of opioid use	24 hours	Measurement of opioid use (mg) for pain control after surgery once patient in recovery area

Secondary Outcome Measures

Name	Time	Method
Measurement of the pain control	24 hours	Measurement of the pain control via numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain.

Trial Locations

Locations (1)

Loyola University Medical Center; 🇺🇸 Maywood, Illinois, United States